| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 42.132 | 78.678 | 90.477 | 142.418 | 172.781 | 182.267 | 241.073 | 250.745 | 273.005 | 309.185 |
| Total Income - EUR | 44.296 | 79.055 | 90.718 | 142.420 | 173.283 | 184.805 | 241.871 | 254.030 | 274.650 | 320.578 |
| Total Expenses - EUR | 50.531 | 60.466 | 66.394 | 77.423 | 99.678 | 105.645 | 132.012 | 163.089 | 163.825 | 161.658 |
| Gross Profit/Loss - EUR | -6.236 | 18.590 | 24.324 | 64.997 | 73.605 | 79.160 | 109.859 | 90.941 | 110.825 | 158.919 |
| Net Profit/Loss - EUR | -7.508 | 17.803 | 22.671 | 63.573 | 71.957 | 77.553 | 107.858 | 88.670 | 108.622 | 149.495 |
| Employees | 6 | 5 | 5 | 5 | 7 | 7 | 7 | 8 | 7 | 6 |
Check the financial reports for the company - Deraclin Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 50.441 | 40.534 | 35.796 | 54.345 | 59.991 | 165.832 | 214.422 | 214.148 | 199.981 | 187.844 |
| Current Assets | 17.562 | 13.801 | 20.349 | 55.526 | 48.813 | 43.540 | 73.357 | 14.854 | 74.879 | 198.030 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 1.087 | 1.827 | 1.699 | 0 |
| Receivables | 1.589 | 4.063 | 8.613 | 14.930 | 24.480 | 17.915 | 19.447 | 8.042 | 32.960 | 28.780 |
| Cash | 15.974 | 9.738 | 11.736 | 40.596 | 24.333 | 25.625 | 52.823 | 4.984 | 40.219 | 169.251 |
| Shareholders Funds | 43.370 | 10.425 | 32.920 | 63.624 | 89.987 | 108.154 | 174.240 | 143.177 | 251.364 | 149.545 |
| Social Capital | 45 | 45 | 44 | 43 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 24.633 | 43.909 | 23.225 | 46.247 | 18.817 | 101.218 | 111.265 | 84.457 | 26.747 | 236.329 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 2.274 | 1.369 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8129 - 8129" | |||||||||
| CAEN Financial Year |
8129
|
|||||||||
Comments - Deraclin Srl